NovaBridge Biosciences
NBP
$4.26
-$0.01-0.23%
NASDAQ
| 06/30/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -20.18% | -44.38% | -- | -35.37% | -- |
| Total Receivables | -- | -36.06% | -- | -47.23% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -94.60% | 822.13% | -- | 105.34% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -93.85% | -- | -93.19% | -- |
| Total Current Assets | -27.26% | -46.44% | -- | -37.18% | -- |
|
|
|||||
| Total Current Assets | -27.26% | -46.44% | -- | -37.18% | -- |
| Net Property, Plant & Equipment | -13.00% | -31.62% | -- | -34.79% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -3.14% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 162.72% | -95.92% | -- | 464.71% | -- |
| Total Assets | -18.56% | -42.35% | -- | -37.46% | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -42.32% | 14.54% | -- | -51.11% | -- |
| Short-term Debt | -- | -- | -- | 54.15% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.74% | 30.35% | -- | -10.93% | -- |
| Total Finance Division Other Current Liabilities | -- | -99.79% | -- | -45.44% | -- |
| Total Other Current Liabilities | -- | -99.79% | -- | -45.44% | -- |
| Total Current Liabilities | -47.42% | -85.46% | -- | -47.04% | -- |
|
|
|||||
| Total Current Liabilities | -47.42% | -85.46% | -- | -47.04% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 54.15% | -- |
| Capital Leases | -18.44% | -5.98% | -- | -29.77% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 20.05% | -- |
| Total Liabilities | -41.99% | -90.88% | -- | -25.03% | -- |
|
|
|||||
| Common Stock & APIC | 0.07% | -0.99% | -- | -0.21% | -- |
| Retained Earnings | -3.04% | -1.76% | -- | -18.33% | -- |
| Treasury Stock & Other | -7.77% | -14.50% | -- | 22.29% | -- |
| Total Common Equity | -16.86% | -17.08% | -- | -42.43% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.86% | -17.08% | -- | -42.43% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.86% | -17.08% | -- | -42.43% | -- |
|
|
|||||